Effectiveness of the Euvichol ® oral cholera vaccine at 2 years: a case-control and bias-indicator study in Haiti

Cholera accounts for a significant burden of morbidity and mortality, with recent years demonstrating an increase in the number of outbreaks globally.[1] As part of comprehensive cholera control efforts, the World Health Organization (WHO) recommends use of oral cholera vaccine (OCV) in endemic and epidemic settings.[2] A global stockpile of WHO pre-qualified OCVs was established in 2013 and has since supplied the majority of OCVs used in outbreak settings.[3]

Source: International Journal of Infectious Diseases - November 22, 2023 Category: Infectious Diseases Authors: Wilfredo R. Matias, Yodeline Guillaume, Gertrude Cene Augustin, Kenia Vissieres, Ralph Ternier, Damien M. Slater, Jason B. Harris, Molly F. Franke, Louise C. Ivers Source Type: research